Pressure Ulcers — Clinical Documentation Guide (2026)

🔍 Definition

A pressure ulcer (also called a pressure injury) is localized damage to the skin and underlying soft tissue, usually occurring over a bony prominence or in relation to a medical or other device. Injury results from intense and/or prolonged pressure, alone or in combination with shear. The tolerance of soft tissue for pressure and shear may also be affected by microclimate, nutrition, perfusion, co-morbidities, and the condition of the soft tissue. Per the National Pressure Injury Advisory Panel (NPIAP), the revised 2016 definition replaced the prior term "pressure ulcer" with pressure injury to capture soft-tissue damage that occurs without an open wound (e.g., Stage 1, Deep Tissue Pressure Injury). Despite this clinical shift, ICD-10-CM retains the heading Pressure ulcer in category L89, and coding professionals must be fluent in both terminologies.

Pressure injuries arise most often in patients who are immobile, malnourished, incontinent, or have diminished sensation. Common high-risk anatomical sites include the sacrum, heels, hips, elbows, ankles, and the back of the head. Facility-acquired pressure injuries Stage 3, Stage 4, and unstageable are Hospital-Acquired Conditions (HACs) under the CMS HAC program, directly affecting reimbursement and quality performance metrics.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

Clinical presentation varies by stage:

• Stage 1: Non-blanchable erythema of intact skin over a bony prominence. Skin is intact; the area may be painful, firm, soft, warmer, or cooler than adjacent tissue. Darker skin tones may not show visible blanching — discoloration, warmth, edema, or induration are alternative indicators.
• Stage 2: Partial-thickness skin loss exposing the dermis. The wound bed is viable, pink or red, moist; may present as an intact or ruptured serum-filled blister. Adipose tissue and deeper structures are not visible.
• Stage 3: Full-thickness skin loss in which adipose tissue is visible; granulation tissue and epibole (rolled wound edges) may be present. Slough and/or eschar may be present. Depth varies by location — areas with significant adiposity can develop extremely deep wounds; areas that lack subcutaneous tissue (bridge of nose, ear, occiput, malleolus) present as shallow Stage 3.
• Stage 4: Full-thickness skin and tissue loss with exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone. Slough and/or eschar may be present. Tunneling and undermining are frequently present.
• Unstageable: Full-thickness skin and tissue loss in which the extent of tissue damage within the wound cannot be confirmed because it is obscured by slough or eschar. Only after enough slough/eschar is removed can the true stage be determined.
• Deep Tissue Pressure Injury (DTPI): Intact or non-intact skin with a localized area of persistent non-blanchable deep red, maroon, or purple discoloration or epidermal separation revealing a dark wound bed or blood-filled blister. Pain and temperature change often precede skin color changes. Prior term was "suspected deep tissue injury" (sDTI).

Systemic signs suggesting secondary infection or complications include fever, leukocytosis, malodorous wound drainage, surrounding cellulitis, crepitus (indicating gas-forming organisms), and osteomyelitis in wounds with bone exposure.

🧭 Differential Diagnosis

📋 Clinical Indicators for Coders/CDI

🦴 Anatomy & Pathophysiology

Pressure injuries result from a combination of external mechanical forces and tissue-level cellular responses. The primary mechanism is ischemia: sustained pressure (typically >32 mmHg — the average capillary closing pressure) occludes cutaneous and deep tissue blood flow, causing hypoxia, nutrient deprivation, and accumulation of metabolic waste products. Reperfusion injury during pressure relief also contributes to cell death through reactive oxygen species.

Shear forces compound ischemia by stretching and tearing blood vessels at the interface between bony anatomy and overlying tissue. Shear most commonly occurs when the head of the bed is elevated above 30 degrees while a patient slides inferiorly. Friction damages the epidermis, creating a portal of entry for pathogens and reducing the mechanical protection of superficial skin layers.

Tissue depth and composition influence which layer sustains injury first. Muscle is far more susceptible to pressure-induced ischemia than skin, which explains why deep tissue injuries (DTPI) can appear as intact-skin presentations while underlying muscle is already necrotic — a critical clinical concept for staging and coding.

The anatomic sites most at risk correspond to bony prominences:

• Sacrum/coccyx — supine patients; most common site
• Heels — second most common; minimal subcutaneous tissue over calcaneus
• Trochanters/hips — lateral recumbent position
• Ischial tuberosities/buttocks — prolonged sitting; wheelchair users
• Elbows, scapulae, occiput — repositioning challenges
• Malleoli, knees, ankles — lateral positioning

Comorbidities that impair skin integrity and healing include diabetes mellitus, peripheral arterial disease, heart failure, renal failure, malnutrition (albumin <3.5 g/dL, prealbumin <16 mg/dL), spinal cord injury, and long-term corticosteroid use. The NPIAP 2016 revised staging system acknowledges that microclimate (moisture and temperature at the skin surface), nutrition, and perfusion are key modifying factors in tissue tolerance.

💊 Medication Impact / Treatment

Pressure ulcers/injuries are primarily managed with wound care, offloading, and nutritional support. Pharmacological agents play an adjunctive, site-specific role. CDI specialists should document any relevant topical or systemic agents that affect healing trajectory or complexity of care.

Topical Agents

• Silver sulfadiazine (SSD) cream — broad-spectrum topical antimicrobial; used in colonized or critically colonized wounds; does not systematically code an infection diagnosis without provider documentation of infection
• Collagenase (Santyl) — enzymatic debridement agent; selectively digests denatured collagen in wound eschar; requires documentation of wound type and clinical indication to support medical necessity; HCPCS supply coding may apply under Part B outpatient settings
• Cadexomer iodine, medical-grade honey (e.g., Medihoney) — antimicrobial wound dressings; coded via HCPCS A-series wound dressing codes
• Becaplermin (Regranex) gel — recombinant PDGF; FDA-approved for diabetic neuropathic ulcers; occasionally used off-label for pressure injuries; boxed warning for remote malignancy risk

Systemic Pharmacology

• Antibiotics (systemic) — reserved for documented cellulitis, bacteremia, osteomyelitis, or sepsis arising from infected pressure ulcer; correct coding requires provider documentation of infection + causative organism when known (e.g., L89.313 + L03.211 right lower leg cellulitis + causative organism code)
• Nutritional supplements — protein supplements (Arginine, zinc, Vitamin C) support wound healing; malnutrition (E40–E46) should be coded when documented to support medical necessity and DRG severity
• Opioid analgesics / neuropathic pain agents — pain management for Stage 3/4 wounds; secondary diagnoses may contribute to complexity

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO CDG members.